SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PARMEGGIANI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.323
EU - Europa 7.990
AS - Asia 7.174
SA - Sud America 1.211
AF - Africa 185
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.021
IT - Italia 4.138
SG - Singapore 2.591
CN - Cina 1.663
BR - Brasile 893
VN - Vietnam 792
DE - Germania 731
UA - Ucraina 629
HK - Hong Kong 625
PL - Polonia 625
GB - Regno Unito 447
FI - Finlandia 383
TR - Turchia 363
FR - Francia 332
BD - Bangladesh 310
RU - Federazione Russa 189
IN - India 181
JP - Giappone 156
CA - Canada 137
AR - Argentina 130
MX - Messico 125
ID - Indonesia 115
NL - Olanda 114
SE - Svezia 114
ZA - Sudafrica 58
IQ - Iraq 55
EC - Ecuador 54
ES - Italia 47
CO - Colombia 45
TH - Thailandia 37
BE - Belgio 33
PH - Filippine 32
AT - Austria 31
PK - Pakistan 29
UZ - Uzbekistan 29
RO - Romania 27
CZ - Repubblica Ceca 26
MY - Malesia 26
KE - Kenya 25
SA - Arabia Saudita 24
CH - Svizzera 23
CL - Cile 23
AU - Australia 22
VE - Venezuela 22
EG - Egitto 19
LT - Lituania 19
KR - Corea 18
IL - Israele 17
MA - Marocco 17
TN - Tunisia 17
NP - Nepal 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
PE - Perù 12
PT - Portogallo 12
AL - Albania 9
AZ - Azerbaigian 9
BG - Bulgaria 9
DO - Repubblica Dominicana 9
JO - Giordania 9
TW - Taiwan 9
IE - Irlanda 8
IR - Iran 8
JM - Giamaica 8
UY - Uruguay 8
BO - Bolivia 7
DK - Danimarca 7
GR - Grecia 7
KZ - Kazakistan 7
OM - Oman 7
CR - Costa Rica 6
DZ - Algeria 6
ET - Etiopia 6
RS - Serbia 6
BY - Bielorussia 5
KG - Kirghizistan 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
EU - Europa 4
PS - Palestinian Territory 4
SN - Senegal 4
TZ - Tanzania 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
CI - Costa d'Avorio 3
GA - Gabon 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
MU - Mauritius 3
MW - Malawi 3
QA - Qatar 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
GH - Ghana 2
HN - Honduras 2
KH - Cambogia 2
Totale 28.879
Salva come PNG Salva come JPEG
Città #
Singapore 1.637
Ashburn 1.339
Fairfield 1.063
Woodbridge 977
San Jose 771
Jacksonville 662
Houston 658
Warsaw 613
Hong Kong 606
Chandler 515
Santa Clara 506
Beijing 499
Seattle 417
Milan 401
Wilmington 397
Ann Arbor 396
Cambridge 349
Dallas 276
Munich 274
Rome 255
Ho Chi Minh City 239
Izmir 237
New York 198
Helsinki 197
Los Angeles 195
Nanjing 181
Hanoi 170
Princeton 157
Lauterbourg 146
Tokyo 139
Bologna 124
Boardman 120
Ferrara 110
Council Bluffs 109
San Diego 85
Naples 79
São Paulo 79
Mexico City 74
Bari 71
Shenyang 67
Jakarta 64
Shanghai 64
Palermo 59
London 57
Dong Ket 54
Orem 53
Chicago 52
Florence 52
Hefei 50
Redwood City 50
Nanchang 49
Jiaxing 47
Montreal 46
Brooklyn 43
Turku 43
Chennai 41
Tianjin 41
Turin 41
Catania 40
Changsha 38
Da Nang 37
Haiphong 37
Verona 37
Moscow 36
Denver 35
Toronto 35
Buffalo 32
Hebei 32
Johannesburg 30
Bremen 29
Genoa 27
San Francisco 27
Atlanta 26
Brussels 26
Dearborn 26
Boston 25
Padova 25
Poplar 25
Venice 25
Addison 24
Falkenstein 24
Mountain View 24
Stockholm 24
Tashkent 24
Cagliari 23
Frankfurt am Main 23
Guangzhou 23
Norwalk 23
Pescara 23
Ankara 21
Kunming 21
Rio de Janeiro 21
Baghdad 20
Belo Horizonte 20
Jinan 20
Phoenix 20
Brasília 19
Charlotte 19
Philadelphia 19
Quito 19
Totale 17.398
Salva come PNG Salva come JPEG
Nome #
EPIDEMIOLOGIA, DIAGNOSI E TRATTAMENTO DELLA COMPLICANZA NEOVASCOLARE SOTTORETINICA 1.556
La gestione clinica e riabilitativa del paziente ipovedente 978
Ibuprofen oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma 726
Fattori di crescita e cellule staminali 604
PATOLOGIE OCULARI IN RELAZIONE CON LE PROBLEMATICHE DELL’IPOVISIONE 560
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 422
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 371
ESAME DEL PAZIENTE AFFETTO DA IPOVISIONE 316
A novel mutation of BEST1 gene in Best disease 310
Eredo-distrofia tapeto-retinica e miopia degenerativa: variabilità fenotipica familiare in tre pazienti di razza caucasica 304
Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study 275
Psoriatic uveitis is not an exploded myth 275
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 269
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 265
Torsional phacoemulsification: A pilot study to revise the “harm scale” evaluating the endothelial damage and the visual acuity after cataract surgery 264
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks 250
A pilot study to propose a "Harm Scale", a new method to predict risk of harm to the corneal endothelium caused by longitudinal phacoemulsification, and the subsequent effect of endothelial damage on post operative visual acuity 243
Anatomical and functional results of patients with late-stage age-related macular degeneration 6 months after smaller-incision new-generation implantable miniature telescope (SING IMT™) implantation 236
Bilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patients. 233
Genetic predictors of response to photodynamic therapy 231
RETINOPATIA PIGMENTOSA: INQUADRAMENTO CLINICO E TERAPEUTICO 222
Carbonic anhydrase inhibitor topical application and optic nerve head blood supply in primary open-angle glaucoma patients 221
PERDITA ENDOTELIALE DOPO ESTRAZIONE EXTRACAPSULARE DI CATARATTA E FACOEMULSIFICAZIONE IN SITU CON IMPIANTO DI LENTE INTRAOCULARE 218
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal) 210
Diabetic retinopathy and endothelin system: Microangiopathy versus endothelial dysfunction 205
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications 198
MicroRNAs as potential biomarkers and innovative therapeutic targets in retinal degenerations 198
Central serous chorioretinopathy: Pathogenesis and management 197
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update 189
Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia 187
Attualita sulla retinite pigmentosa 185
Aflibercept in wet AMD: specific role and optimal use 182
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation 182
Preferential hyperacuity perimetry: perspectives of self-monitoring of neovascular activity in patients with age-related macular degeneration 172
BILATERAL CIRCUMSCRIBED HAEMANGIOMA OF THE CHOROID NOT ASSOCIATED WITH SYSTEMIC VASCULAR SYNDROME. 167
Epiretinal membrane in a 12-year-old immunocompetent girl with cytomegalovirus infection 166
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 164
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 163
Effects of 0.005% latanoprost and 0.5% timolol on circadian intraocular pressure variations in patients with normal tension glaucoma 162
Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene 160
Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma 157
One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study 157
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 156
Reproducibility of retinal thickness measurements with retinal thickness analyser in healthy and glaucomatous subjects 152
LA QUALITÀ VISIVA NEI PAZIENTI CANDIDATI AD INTERVENTI DI CHIRURGIA RIFRATTIVA 150
Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for non-Hodgkin lymphoma 150
CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY ASSOCIATED WITH BILATERAL KERATOCONUS. 150
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 150
Eredo-degenerazioni tapeto-retiniche e cataratta. 148
TRATTAMENTO DEL PAZIENTE IPOVEDENTE 148
Inflammaging: should this term be suitable for age related macular degeneration too? 147
Topical nonsteroidal anti-inflammatory drugs for macular edema 147
Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy 147
Effetti della somministrazione topica di clonidina 0,125% e brimonidina 0,2% sulla pressione di perfusione oculare e sugli indici perimetrici in pazienti in pazienti affetti da glaucoma primario ad angolo aperto 147
Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: A morphologic and functional study 145
Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system 145
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration 144
Are visual disturbances (Excluding diabetic retinopathy) more common in geriatric dm patients? are they risks factor for the progression of disability? 143
Gestione clinica della retinite pigmentosa: up-to.date. 142
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma 138
Incidence, Risk Factors and Effect on Outcomes of Microcystic Macular Edema after Pars Plana Vitrectomy for Retinal Detachment 138
BILATERAL NEURORETINITIS IN A 6-YEAR-OLD BOY WITH ACQUIRED TOXOPLASMOSIS. 137
Choroidal Changes in Myopic Eyes Affected by Choroidal Neovascularization 135
Multiple strokes in a newborn 135
Peripheral intrastromal hydration facilitates safe, deep trephination in corneas of irregular thickness 134
VEGF Levels in the Aqueous Humor of Patients With Wet AMD Treated With Intravitreal Bevacizumab. 133
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration 132
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost 131
The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study 129
Application of artificial intelligence in targeting retinal diseases 129
The influence of diclofenac ophthalmic solution on the intraocular pressure lowering effect of 0.005% latanoprost in glaucomatous patients 124
Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration 124
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. 124
ANOMALIE VASCOLARI RETINICHE NELLA BETA-TALASSEMIA MAJOR 123
Application of artificial intelligence models to predict the onset or recurrence of neovascular age-related macular degeneration 122
null 120
Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia 120
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage 120
Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient 119
ASSESSING THE COST-EFFECTIVENESS OF SWITCHING FROM A BETA-BLOCKER TO LATANOPROST IN THE TREATMENT OF OCULAR HYPERTENSION 119
Retinitis pigmentosa and cystoid macular pattern 118
X-Chromosome Insight for Targeting Gene Therapy 118
Effetti della somministrazione topica di brinzolamide 1% sulla pressione di perfusione oculare e sugli indici perimetrici in pazienti in pazienti affetti da glaucoma primario ad angolo aperto: studio in acuto 117
PATOLOGIE DELL’APPARATO VISIVO 116
Retinitis pigmentosa: genes and disease mechanisms 114
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 114
MODIFICAZIONI DELLA FLORA BATTERICA CONGIUNTIVALE, DEL FILM LACRIMALE E DEGLI ANNESSI OCULARI NEI PAZIENTI ACNEICI IN TERAPIA CON ISOTRETINOINA 111
Total aniridia after nonperforating trauma of a pseudophakic eye: ultrasound biomicroscopic findings 111
Session-by-Session Prediction of Anti-Endothelial Growth Factor Injection Needs in Neovascular Age-Related Macular Degeneration Using Optical-Coherence-Tomography-Derived Features and Machine Learning 110
null 107
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 107
FACOMATOSI 107
Denuded Descemet's membrane supports human embryonic stem cell-derived retinal pigment epithelial cell culture 104
Clinical and rehabilitative management of retinitis pigmentosa: up-to-date 104
null 103
null 102
null 101
Genetic Features of Uveal Melanoma 100
null 99
Somministrazione topica di apraclonidina 1,0% e brimonidina 0,2% in pazienti affetti da glaucoma primario ad angolo aperto: effetti sulla pressione di perfusione oculare e sugli indici perimetrici 98
Totale 20.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.919
Totale 119.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 0 171
2021/20221.648 84 147 144 65 63 70 94 77 59 131 181 533
2022/20231.518 185 59 71 157 249 215 67 124 188 42 92 69
2023/20241.444 123 145 86 81 95 106 93 91 53 164 136 271
2024/20254.305 199 142 320 182 440 407 253 297 673 498 518 376
2025/202610.843 965 497 963 1.334 1.485 633 1.173 641 949 1.185 607 411
Totale 29.171